Your browser doesn't support javascript.
loading
A systematic review and meta-analysis of structural and functional brain alterations in individuals with genetic and clinical high-risk for psychosis and bipolar disorder.
Luna, Licia P; Radua, Joaquim; Fortea, Lydia; Sugranyes, Gisela; Fortea, Adriana; Fusar-Poli, Paolo; Smith, Lee; Firth, Joseph; Shin, Jae Il; Brunoni, Andre R; Husain, Muhammad I; Husian, Muhammad O; Sair, Haris I; Mendes, Walber O; Uchoa, Luiz Ricardo A; Berk, Michael; Maes, Michael; Daskalakis, Zafiris J; Frangou, Sophia; Fornaro, Michele; Vieta, Eduard; Stubbs, Brendon; Solmi, Marco; Carvalho, Andre F.
Afiliación
  • Luna LP; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Hospital, Division of Neuroradiology, Postal Mail: 600 N Wolfe Street Phipps B100F, 21287 Baltimore, USA.
  • Radua J; Imaging of Mood- and Anxiety-Related Disorders (IMARD) group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERSAM, Barcelona, Spain; Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & N
  • Fortea L; Imaging of Mood- and Anxiety-Related Disorders (IMARD) group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERSAM, Barcelona, Spain.
  • Sugranyes G; Multimodal neuroimaging in high risk and early psychosis, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERSAM, Barcelona, Spain; Department of Child and Adolescent Psychiatry and Psychology, Institute of Neuroscience, Hospital Clínic, Barcelona, Spain; Fundació Clínic per a
  • Fortea A; Multimodal neuroimaging in high risk and early psychosis, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERSAM, Barcelona, Spain; Department of Child and Adolescent Psychiatry and Psychology, Institute of Neuroscience, Hospital Clínic, Barcelona, Spain; Fundació Clínic per a
  • Fusar-Poli P; Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, Institute of Psychiatry, Psychology & Neuroscience, Department of Psychosis Studies, King's College London, London, United Kingdom; OASIS Service, South London and Maudsley National Health Service (NHS) Foundation Trust, London, U
  • Smith L; The Cambridge Centre for Sport and Exercise Sciences, Anglia Ruskin University, Cambridge, United Kingdom.
  • Firth J; Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; NICM Health Research Institute, Western Sydney University, Westmead, NSW 2145, Australia.
  • Shin JI; Department of Pediatrics, Yonsei University College of Medicine, Seodaemun-gu, C.P.O., Seoul, Republic of Korea.
  • Brunoni AR; Laboratory of Neurosciences (LIM-27), Department and Institute of Psychiatry, Faculdade de Medicina da Universidade de São Paulo, R Dr Ovidio Pires de Campos 785, 2o andar, São Paulo 05403-000, Brazil; Department of Internal Medicine, Faculdade de Medicina da Universidade de São Paulo & Hospital
  • Husain MI; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
  • Husian MO; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Sair HI; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Hospital, Division of Neuroradiology, Postal Mail: 600 N Wolfe Street Phipps B100F, 21287 Baltimore, USA.
  • Mendes WO; Department of Radiology, Hospital Universitário Walter Cantídio, Postal Mail: 1290 Pastor Samuel Munguba St, Rodolfo Teófilo, 60430-372 Fortaleza, Brazil.
  • Uchoa LRA; Department of Radiology, Hospital Geral de Fortaleza, Postal Mail: 900 Ávila Goulart Street, Papicu, Fortaleza 60175-295, Brazil.
  • Berk M; Deakin University, IMPACT Strategic Research Centre, Barwon Health, School of Medicine, Geelong, Victoria, Australia; Deakin University, CMMR Strategic Research Centre, School of Medicine, Geelong, Victoria, Australia; Orygen, The National Centre of Excellence in Youth Mental Health, The Department
  • Maes M; Deakin University, IMPACT Strategic Research Centre, Barwon Health, School of Medicine, Geelong, Victoria, Australia; Department of Psychiatry, Chulalongkorn University, Faculty of Medicine, Bangkok, Thailand.
  • Daskalakis ZJ; Department of Psychiatry, University of California San Diego, San Diego, CA, USA.
  • Frangou S; Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada; University of Barcelona, Barcelona, Spain; Barcelona Bipolar Disorders and Depressive Unit, Institute of Neurosciences, Hospital Clinic, Barcelona, Spain.
  • Fornaro M; Department of Neuroscience, Reproductive Science and Dentistry, Section of Psychiatr, University School of Medicine Federico II, Naples, Italy.
  • Vieta E; Bipolar and depressive disorders group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERSAM, Barcelona, Spain; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Stubbs B; Department of Psychological Medicine, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.
  • Solmi M; Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, Institute of Psychiatry, Psychology & Neuroscience, Department of Psychosis Studies, King's College London, London, United Kingdom; Department of Psychiatry, University of Ottawa, Ontario, Canada.; Department of Mental Health, The
  • Carvalho AF; IMPACT Strategic Research Centre, Barwon Health, Deakin University School of Medicine, Geelong, Victoria, Australia. Electronic address: andrefc7@hotmail.com.
Article en En | MEDLINE | ID: mdl-35240226
ABSTRACT
Neuroimaging findings in people at either genetic risk or at clinical high-risk for psychosis (CHR-P) or bipolar disorder (CHR-B) remain unclear. A meta-analytic review of whole-brain voxel-based morphometry (VBM) and functional magnetic resonance imaging (fMRI) studies in individuals with genetic risk or CHR-P or CHR-B and controls identified 94 datasets (N = 7942). Notwithstanding no significant findings were observed following adjustment for multiple comparisons, several findings were noted at a more liberal threshold. Subjects at genetic risk for schizophrenia or bipolar disorder or at CHR-P exhibited lower gray matter (GM) volumes in the gyrus rectus (Hedges' g = -0.19). Genetic risk for psychosis was associated with GM reductions in the right cerebellum and left amygdala. CHR-P was associated with decreased GM volumes in the frontal superior gyrus and hypoactivation in the right precuneus, the superior frontal gyrus and the right inferior frontal gyrus. Genetic and CHR-P were associated with small structural and functional alterations involving regions implicated in psychosis. Further neuroimaging studies in individuals with genetic or CHR-B are warranted.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Trastorno Bipolar Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Prog Neuropsychopharmacol Biol Psychiatry Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Trastorno Bipolar Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Prog Neuropsychopharmacol Biol Psychiatry Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos